Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Herold Simon
Internal Medicine · BROOKLYN, NY · NPI 1427034974
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 463 | 109 |
| Eliquis | Apixaban | 250 | 31 |
| Amlodipine Besylate | Amlodipine Besylate | 229 | 56 |
| Gabapentin | Gabapentin | 178 | 41 |
| Nifedipine Er | Nifedipine | 177 | 45 |
| Losartan Potassium | Losartan Potassium | 168 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 152 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 148 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 137 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 135 | 23 |
| Famotidine | Famotidine | 127 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 126 | 32 |
| Simvastatin | Simvastatin | 120 | 18 |
| Levetiracetam | Levetiracetam | 114 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 109 | 23 |
| Furosemide | Furosemide | 103 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 97 | 28 |
| Latanoprost | Latanoprost | 94 | 16 |
| Metformin Hcl | Metformin Hcl | 92 | 31 |
| Levothyroxine Sodium | Levothyroxine Sodium | 91 | 22 |
| Labetalol Hcl | Labetalol Hcl | 85 | 22 |
| Donepezil Hcl | Donepezil Hcl | 81 | 15 |
| Omeprazole | Omeprazole | 79 | 32 |
| Mirtazapine | Mirtazapine | 78 | 21 |
| Lactulose | Lactulose | 77 | 28 |
| Potassium Chloride | Potassium Chloride | 70 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 67 | 17 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 62 | 22 |
| Memantine Hcl | Memantine Hcl | 59 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 57 | 19 |
| Entresto | Sacubitril/Valsartan | 51 | suppressed |
| Finasteride | Finasteride | 51 | 12 |
| Januvia | Sitagliptin Phosphate | 47 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 46 | 15 |
| Baclofen | Baclofen | 45 | 11 |
| Brimonidine Tartrate | Brimonidine Tartrate | 45 | suppressed |
| Glipizide Er | Glipizide | 44 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 43 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 42 | suppressed |
| Lisinopril | Lisinopril | 42 | 14 |
| Mupirocin | Mupirocin | 42 | 15 |
| Enalapril Maleate | Enalapril Maleate | 41 | 12 |
| Hydrochlorothiazide | Hydrochlorothiazide | 40 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 39 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | suppressed |
| Timolol Maleate | Timolol Maleate | 38 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 37 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 36 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 20 |
| Jardiance | Empagliflozin | 35 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 34 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 34 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 33 | suppressed |
| Carvedilol | Carvedilol | 32 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 32 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 30 | 16 |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 29 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | suppressed |
| Tradjenta | Linagliptin | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 27 | suppressed |
| Lumigan | Bimatoprost | 27 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Prednisone | Prednisone | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 24 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 24 | suppressed |
| Invokana | Canagliflozin | 23 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 23 | 12 |
| Olanzapine | Olanzapine | 23 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 22 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 22 | suppressed |
| Spironolactone | Spironolactone | 22 | suppressed |
| Atenolol | Atenolol | 21 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 21 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 14 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 19 | 11 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 19 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 19 | 11 |
| Haloperidol | Haloperidol | 19 | suppressed |
| Novolog | Insulin Aspart | 19 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 19 | 11 |
| Calcitriol | Calcitriol | 18 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 18 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 18 | suppressed |
| Risperidone | Risperidone | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Meloxicam | Meloxicam | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Procrit | Epoetin Alfa | 17 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 17 | suppressed |
| Sodium Chloride | Sodium Chloride 0.45 % | 17 | suppressed |
| Xifaxan | Rifaximin | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 14 |
| Glipizide | Glipizide | 16 | suppressed |
| Lidocaine | Lidocaine | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 16 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 16 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 15 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 14 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 13 | suppressed |
| Isentress Hd | Raltegravir Potassium | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Zidovudine | Zidovudine | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Levofloxacin-D5w | Levofloxacin In Dextrose 5 % | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | suppressed |
| Propylthiouracil | Propylthiouracil | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Tivicay | Dolutegravir Sodium | 12 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Calcium Acetate | Calcium Acetate | 11 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error